Hansa Biopharma AB (publ) (STO:HNSA)
Sweden · Delayed Price · Currency is SEK 31.20
+0.54 (1.76%)
Oct 31, 2025, 12:59 PM CET
Hansa Biopharma AB Employees
Hansa Biopharma AB had 135 employees as of December 31, 2024. The number of employees decreased by 33 or -19.64% compared to the previous year.
Employees
135
Change (1Y)
-33
Growth (1Y)
-19.64%
Revenue / Employee
1.28M SEK
Profits / Employee
-4.58M SEK
Market Cap
3.18B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 135 | -33 | -19.64% |
| Dec 31, 2023 | 168 | 18 | 12.00% |
| Dec 31, 2022 | 150 | 19 | 14.50% |
| Dec 31, 2021 | 131 | 44 | 50.57% |
| Dec 31, 2020 | 87 | 13 | 17.57% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Medicover AB | 47,256 |
| Getinge AB | 11,791 |
| Nolato AB | 5,837 |
| Elekta AB | 4,556 |
| Asker Healthcare Group AB | 4,030 |
| AddLife AB | 2,181 |
| Swedish Orphan Biovitrum AB | 1,806 |
| Sectra AB | 1,296 |
Hansa Biopharma AB News
- 2 days ago - Hansa Biopharma AB (publ) (HNSBF) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 3 days ago - Hansa Biopharma Reports Third Quarter and Interim Year to Date 2025 Financial Results - PRNewsWire
- 4 days ago - Hansa hosts call with distinguished transplant surgeons: Insights on clinical practice and imlifidase Phase 3 Results - PRNewsWire
- 5 weeks ago - Hansa Biopharma AB (publ) Discusses on ConfIdeS US Phase 3 Pivotal Trial Topline Results Presentation - Seeking Alpha
- 5 weeks ago - Hansa Biopharma AB (publ) - Special Call - Seeking Alpha
- 5 weeks ago - Hansa Biopharma AB (Publ) Discusses On ConfIdeS US Phase 3 Pivotal Trial Topline Results Call (Transcript) - Seeking Alpha
- 3 months ago - Hansa Biopharma announces key executive appointments to support continued growth - PRNewsWire
- 3 months ago - Hansa Biopharma AB (publ) 2025 Q2 - Results - Earnings Call Presentation - Seeking Alpha